Quala Dental Topical Anesthetic Gel Recalled for Manufacturing Equipment Defect
Quala Dental Products topical anesthetic gel (20% benzocaine) is recalled due to manufacturing equipment defects. The bulk product was inadvertently released despite Quality Unit rejection after inspection found scratches on the mixing vessel.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving manufacturing defects (scratches on the mixing vessel) that create a contamination risk in a product applied to oral tissues. Although no illnesses or injuries have been reported, the defect poses a risk of harm to users and meets the criterion for 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
Quala Dental Products Topical Anesthetic Gel containing 20% benzocaine (Lot No. BNZ-001646, expiration date 11/26/2026) is being recalled.
The U.S. Food and Drug Administration issued this Class II recall due to manufacturing (CGMP) deviations. During routine inspection of the production mixing vessel, scratches were discovered on the sides and bottom. Although the Quality Unit rejected the bulk product upon discovery of these defects, the product was inadvertently released and shipped to customers.
The recalled product was distributed nationwide in the United States and Canada, as well as to the Dominican Republic, El Salvador, Honduras, and Qatar. The product manufacturer is Keystone Industries, made for NDC, Inc., located at 407 New Sanford Road, La Vergne, TN 37086.
The recalled product
- Product
- Quala Dental Products, Topical Anesthetic Gel, Contains 20% Benzocaine, Net Contents: 1 oz (30g), Gluten Free, Quala Dental Products, Made in USA for: NDC, Inc, 407 New Sanford Road, La Vergne, TN 37086, www.quala.com
- Manufacturer
- Keystone Industries
- Category
- Drug — Topical Anesthetic
- Hazard
- contamination-risk
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot No.: BNZ-001646
- Exp Date: 11/26/2026
- Keystone Item No. 03-64419
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27